Renal Implications of Long-Term Systemic Bevacizumab for Recurrent Respiratory Papillomatosis
Cal Robinson(University of Toronto), Paolo Campisi(University of Toronto), Michael Hart-Matyas(Hospital for Sick Children), Daniel A. Morgenstern(University of Toronto), Damien Noone(Hospital for Sick Children)
Cited by 9
Related Papers
The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations
|Nature Cancer|2022|127
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results
|Nature Medicine|2023|125
DNA Polymerase and Mismatch Repair Exert Distinct Microsatellite Instability Signatures in Normal and Malignant Human Cells
|Cancer Discovery|2020|85
High Blood Pressure in Children and Adolescents: Current Perspectives and Strategies to Improve Future Kidney and Cardiovascular Health
|Kidney International Reports|2022|81